These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 22387030)

  • 1. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility.
    Kim PN; Choi D; Rhim H; Rha SE; Hong HP; Lee J; Choi JI; Kim JW; Seo JW; Lee EJ; Lim HK
    J Vasc Interv Radiol; 2012 May; 23(5):627-34. PubMed ID: 22387030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
    Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1-3 cm): value of fusion imaging with conventional US and CT/MR images.
    Lee MW; Rhim H; Cha DI; Kim YJ; Lim HK
    J Vasc Interv Radiol; 2013 Jul; 24(7):958-65. PubMed ID: 23796082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mistargeting after fusion imaging-guided percutaneous radiofrequency ablation of hepatocellular carcinomas.
    Lim S; Lee MW; Rhim H; Cha DI; Kang TW; Min JH; Song KD; Choi SY; Lim HK
    J Vasc Interv Radiol; 2014 Feb; 25(2):307-14. PubMed ID: 24315550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intra-tumoural fat on MRI predict visibility of small (≤3 cm) hepatocellular carcinomas during ultrasound-guided tumour ablation?
    Hui TCH; Huang IKH; Lau WK; Pua U
    Clin Radiol; 2018 Mar; 73(3):254-258. PubMed ID: 29129265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
    Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
    Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
    J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection.
    Lee MW; Kim YJ; Park HS; Yu NC; Jung SI; Ko SY; Jeon HJ
    AJR Am J Roentgenol; 2010 May; 194(5):W396-400. PubMed ID: 20410384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
    Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
    J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
    Rhim H; Lim HK; Kim YS; Choi D
    AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
    Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
    Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation.
    Kim YJ; Lee MW; Park HS
    Abdom Imaging; 2013 Feb; 38(1):98-111. PubMed ID: 22467060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.